The epidemiology of Huntington's disease in Northern Ireland
- PMID: 7562964
- PMCID: PMC1050544
- DOI: 10.1136/jmg.32.7.524
The epidemiology of Huntington's disease in Northern Ireland
Abstract
A survey of Huntington's disease (HD) in Northern Ireland, with a population of 1.5 million, has shown a 1991 prevalence rate of 6.4/100,000. Virtually complete ascertainment was achieved, enabling prevalence rate estimates and age statistics to be calculated over the last 20 years. The prevalence rate is similar to the high prevalence rates of HD found in most European populations, suggesting the presence of either one extremely ancient or a number of separate mutational origins, resulting in a uniform European HD prevalence. The ages at diagnosis and duration of the disease are similar to previous studies, suggesting a consistent effect of the HD gene in all families. Estimates of heterozygote frequency (HF), direct and indirect mutation rate, fertility, and genetic fitness (W) were made. Reliable HF estimates gave values between 10 and 11 x 10(-5). The direct and indirect mutation rates were 0.32 x 10(-6) and 1.05 x 10(-6) respectively. W was increased in the affected HD population but decreased in the at risk population. Fertility in HD is not reduced, but it appears that at risk patients have actively limited their family size. Factors responsible include, among others, the fear of developing HD and genetic counselling of families. This is the first published epidemiological survey to include ascertainment data in a population both before and after isolation of the HD gene, and with the diagnosis in virtually all patients confirmed by DNA mutation testing.
Similar articles
-
Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing.J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):337-42. doi: 10.1136/jnnp.2004.036806. J Neurol Neurosurg Psychiatry. 2005. PMID: 15716522 Free PMC article.
-
Significant linkage disequilibrium between the Huntington's disease locus and markers at loci D4S10, D4S95, and D4S111 in Northern Ireland.J Med Genet. 1993 Dec;30(12):1018-9. doi: 10.1136/jmg.30.12.1018. J Med Genet. 1993. PMID: 8133499 Free PMC article.
-
Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk.Mov Disord. 2014 Jan;29(1):105-14. doi: 10.1002/mds.25717. Epub 2013 Oct 21. Mov Disord. 2014. PMID: 24151181
-
The epidemiology of Huntington's disease.Hum Genet. 1992 Jun;89(4):365-76. doi: 10.1007/BF00194305. Hum Genet. 1992. PMID: 1535611 Review.
-
Epidemiology of Huntington disease.Handb Clin Neurol. 2017;144:31-46. doi: 10.1016/B978-0-12-801893-4.00003-1. Handb Clin Neurol. 2017. PMID: 28947124 Review.
Cited by
-
Frequency of Usher syndrome in two pediatric populations: Implications for genetic screening of deaf and hard of hearing children.Genet Med. 2010 Aug;12(8):512-6. doi: 10.1097/GIM.0b013e3181e5afb8. Genet Med. 2010. PMID: 20613545 Free PMC article.
-
From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington's Disease Research.Int J Mol Sci. 2023 Aug 21;24(16):13021. doi: 10.3390/ijms241613021. Int J Mol Sci. 2023. PMID: 37629202 Free PMC article. Review.
-
Familial autosomal dominant dopa responsive Parkinson's disease in three living generations showing extreme anticipation and childhood onset.J Med Genet. 1996 Jun;33(6):504-6. doi: 10.1136/jmg.33.6.504. J Med Genet. 1996. PMID: 8782052 Free PMC article.
-
Huntington's disease: the coming of age.J Genet. 2018 Jul;97(3):649-664. J Genet. 2018. PMID: 30027901 Review.
-
What do we know about Late Onset Huntington's Disease?J Huntingtons Dis. 2017;6(2):95-103. doi: 10.3233/JHD-170247. J Huntingtons Dis. 2017. PMID: 28671137 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous